Medical professionals and clinicians are always focusing on reducing the dose of radiations. However, the need for a better radiation dose management is increasing owing to the high reliance on high-dose imaging modalities for effective diagnosis and treatment. Radiography, nuclear imaging, and tomography are some of the imaging modalities that require radiation dose monitoring.
Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/radiation-dose-management-market-101228
It was Philips’s DoseWise, a radiation dose management software that could track and record the amount of radiation exposure in clinicians and patients. Radiation exposure is still a concern affecting healthcare professionals and patients. This is where radiation dose management plays a significant role as the system helps to achieve desirable radiation exposure.
These systems not only can monitor, optimize, and evaluate radiation dose, by offering real-time insights. Spurred by this factor, the radiation dose management market is expected to soar in the foreseeable future. For instance, GE’s Dose Excellence Program offers insights into radiation dose practices by data and analytics with an aim to deliver unhindered imaging.
some of the leading players operating in the global radiation dose management market include:
- Koninklijke Philips N.V.,
- Sectra AB
- Siemens Healthcare Private Limited
- FUJIFILM Holdings Corporation
- PACSHealth, LLC.
- General Electric Company
- Bayer AG
- Infinitt Healthcare Co. Ltd.
Decision-making Process of Healthcare Experts to Bolster Adoption of Radiation Dose Management System
Patients and physicians around the world are increasingly becoming aware of radiation safety, augmenting the radiation dose management market growth. A lead analyst at Fortune Business Insights says, “Radiation dose management systems offer insights, helping healthcare experts in the decision-making process while performing medical imaging procedures.” He added, “Improper radiation exposure can result in damaged blood cells, high cancer risk, acute illness, and other genetic disorders.” Considering this, organizations such as National Council on Radiation Protection and Measurements (NCRP), American Association of Physicists in Medicine (AAPM), American College of Radiology (ACR), and American College of Cardiology (ACC) are created guidelines for an acceptable radiation dose in patients. Enabled by this, the radiation dose management market potential is likely to increase over the projected horizon.
An increasing number of imaging system installations, coupled with rapid developments in healthcare infrastructure, act as a potential growth triggers. On the downside, poor infrastructure in developing nations and high cost associated with the radiation dose management software may hamper the growth of the market.
By Imaging Modality
- Nuclear Imaging
- Interventional Imaging
- Ambulatory Surgery Centers
- Diagnostic Centers
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)
Cancer Risk to Increase After Radiation Exposure, Stoking Demand for Systems in North America
The radiation dose management market in North America is expected to dominate through the forecast years. This is attributable to the rising prevalence of diseases caused by radiation exposure. According to a study conducted by the American Heart Association Journal (AHAJ) in 2018, a patient’s risk of getting diagnosed by cancer increased after first ten radiation exposures. This took place when technicians were performing computed tomography angiography procedures.
The market in Asia Pacific is likely to register a moderate growth owing to the lack of standard guidelines, especially in emerging countries and the high cost of such systems. Nonetheless, growing healthcare infrastructure and improving technology are likely to offer a favourable growth environment for the market in the forthcoming years.
Several companies are adopting strategies to expand their product portfolio and maintain their competitive edge. For instance, ControlRad’s new medical technology called ControlRad Trace receives FDA clearance in May 2019. This technology can be integrated into mobile C-arms and focusses on reducing radiation exposure during fluoroscopic procedures. It can reduce unnecessary radiations by 89%, without affecting the image quality.
More Trending Topics from Fortune Business Insights: